Clinical Trials Logo

Stage I Breast Cancer AJCC v7 clinical trials

View clinical trials related to Stage I Breast Cancer AJCC v7.

Filter by:

NCT ID: NCT02276443 Recruiting - Clinical trials for Invasive Breast Carcinoma

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Start date: November 9, 2015
Phase: N/A
Study type: Interventional

This clinical trial assesses whether a newly designed algorithm which looks at the genomic signature of each patient's tumor to predict their sensitivity to standard of care treatment verses being placed on a personally designed treatment trial can improve the responses in patients with newly diagnosed triple-negative breast cancer (TNBC). Testing the primary tumor biopsy for certain proteins and monitoring the lymphocyte infiltration into the tumors may help doctors determine the sub-type of TNBC, and direct treatments that may work well. It is not yet known whether assigning treatment based on the patient's tumor classification will improve how well the tumor responds.

NCT ID: NCT01245712 Active, not recruiting - Clinical trials for Invasive Breast Carcinoma

Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer

Start date: November 15, 2010
Phase: Phase 2
Study type: Interventional

This phase II trial studies the side effects and how well radiation therapy works in treating patients with stage 0-II breast cancer. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.